Takashi Kanamori

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of <i>CDX2</i> and <i>IDH1/2</i> mutations

Takahiko Yasuda, Masashi Sanada, Masahito Kawazu et al. · Blood · 2021 · 53 citations · Full text

Medicine, Hematology, Oncology +10

Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma

Takuto Tachita, Shiori Kinoshita, Masaki Ri et al. · Cancer Science · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15

The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib

Yoshinori Mori, Shiori Kinoshita, Takashi Kanamori et al. · Internal Medicine · 2018 · 23 citations · Full text

Medicine, Oncology, Surgery +15

Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma

Shiori Kinoshita, Masaki Ri, Takashi Kanamori et al. · Oncology Letters · 2018 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study

Takahiko Yasuda, Masashi Sanada, Dai Nishijima et al. · Cancer Science · 2020 · 13 citations · Full text

Medicine, Hematology, Oncology +17